Certain Drug Therapies for Pregnant Women with IBD Can Have Impact on Newborns

Certain Drug Therapies for Pregnant Women with IBD Can Have Impact on Newborns
Infants born to women who were treated with antibodies against tumor necrosis factor alpha (TNF alpha) during pregnancy have detectable levels of antibodies until 12 months of age, according to the results of a recent study, “Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection,” published in the journal Gastroenterology. Treatment for inflammatory bowel disease (IBD) relies on antibodies against TNF alpha, such as the drugs adalimumab and infliximab. Pregnant women with IBD are often treated with anti-TNF alpha antibodies to prevent or reduce the chanc
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *